P incorporation into N-T, C-T and truncations of C-T of GIRK4. Numbers in upper case confer to the aminoacid range of the truncations within the hGIRK4 sequence (see also Figure 5 ). The number of individual phosphorylation experiments is shown in parenthesis above each bar. **, (***): the mean value deviates statistically significant from zero at the p<0.01 (0.001) level. oocytes from three different batches were used for calculation of mean values. GIRK4 * denotes the homooligomeric construct. ***: the mean value deviates significantly from GIRK4 * at the p<0.001 level. Figure S2B : Effect of mutation of single S/Ts on the ratio of I cAMP vs. I ACh (cAMP was injected during agonist application). Since mutation of S75, S191, T199, S412 and S418 exhibited profound and differential effects on the ratio I ACh /I HK (see panel S2A), cAMP effects were normalized to the size of I ACh of the corresponding mutation and oocyte, in order make the results better comparable. Same oocytes as in S2A. *: the mean value deviates significantly from GIRK4 * at the p<0.05 level.
SUPPLEMENTARY TABLES:
Supplementary Table S1 .:
Sequence of the primers used for site directed mutagenisis. For S418 two different pairs of primers were used, depending whether the insert was located in pGEX-4T1 or the pMXT vector.
Supplementary Table S2.:
Sequence of the primers used for generation of truncated GST fusion protein encoding inserts.
Primer Sequence T57  S75  S191  T199  S227  T244  T255  S277  S284  S321  T334  S382  S412 
